Evidence map›Paper›PMID 36284405›Full record

ArticleEuropean journal of cancer care2022

Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.

Melissa Barbati, Michal Kicinski, Stefan Suciu, Françoise Mazingue, Els Vandecruys, Geneviève Plat, Anne Uyttebroeck, Catherine Paillard, Marie-Françoise Dresse, Pauline Simon and 14 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of cancer care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 2 countries.

Melissa BarbatiDepartment of Pediatric Hematology-Oncology, CHRU Lille, Lille, France.ORCID https://orcid.org/0000-0003-1526-7405
Michal KicinskiStatistics Department, EORTC Headquarters, Brussels, Belgium.
Stefan SuciuStatistics Department, EORTC Headquarters, Brussels, Belgium.
Françoise MazingueDepartment of Pediatric Hematology-Oncology, CHRU Lille, Lille, France.
Els VandecruysDepartment of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
Geneviève PlatDepartment of Hematology, CHU Toulouse, Toulouse, France.
Anne UyttebroeckDepartment of Pediatric Hemato-Oncology, University Hospital Leuven, Leuven, Belgium.
Catherine PaillardDepartment of Pediatric Hematology-Oncology, CHRU Strasbourg, Strasbourg, France.
Marie-Françoise DresseDepartment of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
Pauline SimonPediatric Oncology, CHRU Besançon, Besançon, France.
Claire PluchartDepartment of Pediatric Haematology and Oncology, CHU Reims, Reims, France.
Odile MinckesDepartment of Pediatric Hematology-Oncology, CHU Caen, Caen, France.
Alina FersterDepartment of Hemato-Oncology, HUDERF (ULB), Brussels, Belgium.
Claire FreyconDepartment of Pediatric Hematology-Oncology, CHU Grenoble, Grenoble, France.
Frederic MillotDepartment of Pediatric Hematology-Oncology, CHU Poitiers, Poitiers, France.
Jutte Van Der Werff Ten BoschVUB, Brussels, Belgium.
Christophe ChantrainCHC Mont Legia, Liège, Belgium.
Robert PaulusCHR Verviers East Belgium, Verviers, Belgium.
Gaetan de SchaetzenEORTC Headquarters, Brussels, Belgium.
Giovanna RossiMedical Department, EORTC Headquarters, Brussels, Belgium.
Pierre RohrlichPediatric Oncology, CHU Nice, Nice, France.
Yves BenoitDepartment of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
Caroline PietteDepartment of Paediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
European Organisation for Research and Treatment of Cancer (EORTC) Children's Leukemia Group (CLG)
European Organisation for Research and Treatment of Cancer · BECentre Hospitalier Universitaire de Lille · FRGhent University Hospital · BEUniversity of Liège · BECentre Hospitalier Chrétien · BECentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Poitiers · FRCentre Hospitalier Universitaire de Reims · FRCentre Hospitalier Universitaire de Toulouse · FRCHR Verviers · BEHôpitaux Universitaires de Strasbourg · FRKU Leuven · BEQueen Fabiola Children's University Hospital · BE

Funding

Fonds Cancer (FOCA)KinderkankerfondsKU Leuven
6 · The paper itself

Abstract

objectiveThe objective of this study is to evaluate the socio-economic outcomes of survivors of childhood acute lymphoblastic leukaemia (ALL).

methodsChildhood ALL adult survivors, enrolled in EORTC trials between 1971 and 1998 in France and Belgium, were invited to fill out a questionnaire with information about their socio-economic situation (living with a partner, having a university degree, having a job, working part time and history of having a paid job). The outcomes were compared with two matched control populations.

resultsAmong 1418 eligible patients, 507 (35.8%) participated, including 39 (8%) and 61 (12%) patients who received a haematopoietic stem cell transplantation (HSCT) and a cranial radiotherapy (CRT), respectively. The median time to follow-up was 20 years, and median age was 25 years. Survivors showed a socio-economic level at least as good as controls. HCST and CRT were associated with a higher probability of not obtaining a bachelor degree (respectively OR = 3.49, 95% CI: 1.46-8.35 and OR = 2.31, 95% CI: 1.04-5.15), HSCT was associated with unemployment (OR = 2.89, 95% CI: 1.09-7.65) and having a relapse was associated with a higher probability of not having a partner (OR = 1.88, 95% CI: 1.01-3.51) adjusting for confounders.

conclusionChildhood ALL survivors showed a high level of socio-economic participation. HCST and CRT were associated with poorer functioning.

Indexed as

Precursor Cell Lymphoblastic Leukemia-LymphomaSurvivorsAdultCranial IrradiationEmploymentHumansMarital Statuschildhood ALLeducational achievementemploymentlong-term cancer survivorsmarital statussocio-economic status

Identifiers

PMID36284405
PMCPMC9787328
OpenAlexW4307338955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.